Reductions in Plaque, Inflammation Appear to Explain Statin Benefit in HIV

A REPRIEVE trial substudy shows 2 years of pitavastatin lessened noncalcified plaque volume and risk of plaque progression.

Related Keywords

Philadelphia ,Pennsylvania ,United States ,San Francisco ,California ,Boston ,Massachusetts ,American ,Michael Lu ,American College Of Cardiology ,Us Preventive Services Task ,Md University Of California ,American Heart Association ,Massachusetts General Hospital ,Priscilla Hsue ,American College ,Services Task ,